Bucillamine (CAS 65002-17-7) Suppliers and Product Information

Bucillamine is an orally active immunomodulator used in the treatment of rheumatoid arthritis. It is more potent than penicillamine in inhibiting collagenase activity and inactivating rheumatoid factor. Bucillamine has shown significant improvements over placebo in erythrocyte sedimentation, grip power, joint swelling, and duration of morning stiffness in clinical studies.

Frequently Asked Questions about Bucillamine

Q: What is the main use of Bucillamine?

A: Bucillamine is primarily used as an antirheumatic agent for the treatment of rheumatoid arthritis.

Q: How should Bucillamine be stored?

A: Bucillamine should be stored at -20°C in a freezer under an inert atmosphere due to its air sensitivity and hygroscopic nature.

Q: What is the solubility of Bucillamine?

A: Bucillamine is slightly soluble in ethanol, methanol, and water. It is very slightly soluble in DMSO.

Q: Is Bucillamine approved by regulatory agencies?

A: Some suppliers, like Dideu Industries Group Limited, claim to be FDA/GMP/CEP approved manufacturers of Bucillamine. However, it's important to verify the regulatory status with the specific supplier and relevant authorities for your intended use.